Sequenom, Inc. (NASDAQ:SQNM)

CAPS Rating: 3 out of 5

A genetics company committed to providing genetic analysis products and services that translate genomic science into superior solutions for the biomedical research, molecular medicine, agricultural, and non-invasive prenatal testing markets.

Recs

4
Player Avatar perinatal (68.98) Submitted: 4/20/2011 12:22:54 PM : Outperform Start Price: $6.99 SQNM Score: -37.60

Sequenom will eventually figure out a way to perform non-invasive testing for Down syndrome.

Featured Broker Partners


Advertisement